Multiple Sclerosis Clinical Trials in Philadelphia

Showing 81-100 of 634 trials

Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2

NCT07321327

The purpose of this study is to pilot test for feasibility and initial promise an implementation strategy resource package that aims to support caregivers in using behavioral interventions for children with hyperactive, inattentive, or impulsive behaviors, when provided as an adjunct to a resource package for teachers. Participating children will be randomized at the classroom level to one of two conditions: a) their teacher and caregiver receive the resource package, or b) only their teacher receive the resource package. The research team will examine teacher and caregiver implementation outcomes and mental health outcomes for enrolled children.

Attention Deficit Hyperactivity Disorder Symptoms

Children's Hospital of Philadelphia100 participantsStarted Feb 2026

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

NCT03541200

An open-label, long term extension study of MT-8554 in postmenopausal women experiencing moderate to severe vasomotor symptoms who completed Study MT-8554-A01

Vasomotor Symptoms (VMS)

Tanabe Pharma America, Inc.190 participantsStarted Apr 2018

Birmingham, Alabama, United States • Dothan, Alabama, United States • Phoenix, Arizona, United States +50 more locations

Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Multiple Sclerosis Trials in Other Cities

Persistent Post-Concussion Symptoms With Convergence Insufficiency

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Early Onset Colorectal Cancer Detection

Other Conditions in Philadelphia